Circulating Levels of Adipokines and TNF in Patients with and without Type 1 Diabetes

Authors

  • Anila Jaleel Shalamar Medical and Dental College Lahore
  • Adnan Zuberi Chemical Pathology, Ziauddin University, Karachi, Pakistan.
  • Bilal Aheed Department of Biochemistry, Ziauddin University, Karachi, Pakistan.
  • Shahnila Jaleel Department of Biochemistry, Ziauddin University, Karachi, Pakistan.

Keywords:

HOMA-IR, Adiponectin, Resistin, Visfatin, Insulin

Abstract

Objective: The aim of this study was to evaluate circulating levels of adiponectin, resistin, visfatin and TNF in type1 diabetic children and young adolescents.

Patients and Methods:
Design: Cross-sectional study
Setting: Ziauddin University Karachi Subjects: 90 subjects (30 type I diabetic (T1DM) subjects and 60 non-diabetic controls) between the age of 05-15 years.
Methods: Serum adiponectin, resistin, visfatin, TNF and insulin were measured using ELISA and fasting blood sugar by glucose oxidase (Standard Kit method).

Results: Out of 90 study subjects, 30 were type 1 diabetic patients and 60 non-diabetic controls. Increased levels of serum adiponectin levels were significant in type I diabetic subjects (TIDM) (10.83+1.73) compared with controls (9.07+1.25). Same pattern was observed for serum TNF in diabetic subjects (10.82+4.53) compared with controls (7.22+ 2.22). Significantly increased serum visfatin levels were found in TIDM patients (10.89+2.72) compared with controls (4.97+1.57). Significant negative correlation was observed between TNF and resistin (r=-0.356), adiponectin and age (r= - 0.594), and glucose and insulin in TIDM patients (r= -0.588). Binary logistic shows significant association of HOMA IR, adiponectin and visfatin with Type 1 diabetes mellitus.
Level of significance set for the study was P=0.05.
Conclusion: Increased levels of circulating adipocytokines in Type I diabetic children depict the important role of cytokines in Type I diabetic patients. However, increased adiponectin concentration in type I diabetic subjects needs to be further explored in large-scale studies.

Downloads

Download data is not yet available.

References

Badenhoop K, Schwarz G, Trowsdale J, Lewis V, Usadel KH, Gale EA, et al. TNF alpha gene polymorphism in Type 1 Insulin dependent diabetes mellitus Diabetologica 1989; 32:445-8.

Linebaugh K. Type 1 Diabetes on rise among youth. Wall Street J 2012; June 10.

Shalev A, Patterson NB, Hirshberg B, Rother KI, Harlam DM. Resistin serum levels in type 1 diabetes pre- and post-islet transplantation. Metabolism 2004; 53:403-4.

Schäffler A, Büchler C, Müller-Ladner U, Herfarth H, Ehling A, Paul G, et al. Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus Horm Metab Res 2004; 36:702-7.

Akash MS, Rehman K, Chen S. Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus J Cell Biochem 2013; 114:525-31.

Donath MY, Shoelson SE. Type 2 diabetes in as an inflammatory disease. Nat Rev Immunol 2011; 11:98-107.

Celi F, Bini V, Papi F, Santilli E, Castellani MS, Ferretti A, et al. Circulating adipocytokines in non-diabetic and Type 1 diabetic children: relationship to insulin therapy, glycaemic control and pubertal development. Diabetic Medicine 2006; 660-5.

Hedblad B, Nilsson P, Janzon L, Berglund G: Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects: results from a cross-sectional study in Malmo, Sweden. Diabet Med 2000; 17:299-307.

Flier JS, Kahn CR, Roth J. Receptor, antireceptor antibodies and mechanism of insulin resistance. N Eng J Med 1979; 300:413-9.

Postman T, Kiessig ST: Enzyme immunoassay techniques: An overview. Immunol Methods 1992;

:5-21.

Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. The fat-derived hormone adiponect in reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001; 7:941-6.

Haque WA, Shimomura I, Matsuzawa Y, Garg A. Serum adiponectin and leptin levels in patients with lipodystrophies. J Clin Endocrinol Metab 2002; 87:2395-8.

Imagawa A, Funahashi T, Nakamura T, Moriwaki M, Tanaka S, Nishizawa H, et al. Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes. Diabetes Care 2002; 25:1665-6.

Perseghin G, Lattuada G, Danna M, Sereni LP, Maffi P, De Cobelli F, et al. Insulin resistance, intramyocellular lipid content, and plasma adiponectin in patients with type 1 diabetes. Am J Physiol Endocrinol Metab 2003; 285:1174-81.

Stefan N, Bunt JC, Salbe AD, Funahashi T, Matsuzawa Y, Tataranni PA. Plasma adiponectin concentrations in children: relationships with obesity and insulinemia. J Clin Endocrinol Metab 2002; 87:4652-6.

Jaber-Al-Ahmed Adiponectin and Type 1 Diabetes Mellitus in Children. Indian Pediatr 2012; 49:267-8.

McEntegart MB, Awede B, Petrie MC. Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines and B-type natriuretic peptide. Eur Heart J 2007; 7:829-35.

Diez JJ, Iglesias P. The role of the novel adipocyte derived hormone adiponectin in human disease. Eur j Endocrinol 2003; 148:293-300.

Galler A, Gelbrich G, Kratzsch J, Noack N, Kapellen T, Kiess W. Elevated serum levels of adiponectin in children,

adolescents and young adults with type 1 diabetes and the impact of age, gender, body mass index and metabolic control: a longitudinal study. Eur J Endocrinol 2007; 157:481-9.

Habeeb MM, Youssef OI, Saab AA, El Hadidi ES. Adiponectin as a marker of complications in children with type 1 diabetes. Indian Pediatr 2012; 49:277-80.

Fehmann HC, Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res 2002; 34:671-3.

Goldberg RB. Cytokine and Cytokine-Like Inflammation Markers, Endothelial Dysfunction, and Imbalanced Coagulation in Development of Diabetes and its Complications. J Endocrinol Metab 2009; 94:3171-82.

Toruner F, Altinova AE, Bukan N, Arslan E, Akbay E, Ersoy R, et al. Plasma visfatin concentrations in subjects with type 1 diabetes mellitus. Horm Res 2009; 72:33-7.

Stadler M, Storka A, Theuer EA, Krebs MV, Elena PN, Giovanni P, et al. Adipokines in type 1 diabetes after successful pancreas transplantation: normal visfatin and retinol-binding-protein-4, but increased total adiponectin fasting concentrations. Clin Endocrinol

; 72:763-9.

Downloads

Published

2013-04-28

How to Cite

Jaleel, A., Zuberi, A., Aheed, B., & Jaleel, S. (2013). Circulating Levels of Adipokines and TNF in Patients with and without Type 1 Diabetes. Journal of the Dow University of Health Sciences (JDUHS), 7(1), 10–14. Retrieved from https://mail.jduhs.com/index.php/jduhs/article/view/1557

Issue

Vol. 7 No. 1

Section

Original Articles

License

Copyright (c) 2021 Anila Jaleel, Adnan Zuberi, Bilal Aheed, Shahnila Jaleel

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Articles published in the Journal of Dow University of Health Sciences are distributed under the terms of the Creative Commons Attribution Non-Commercial License https://creativecommons.org/ licenses/by-nc/4.0/. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal.